These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 15850135)

  • 1. Comparison of the amelioration effects of two enzyme inducers on the inflammatory process of experimental allergic encephalitis (EAE) using immunohistochemical technique.
    El-Gouhary I; Mohamed A; Suleiman S; Benghuzzi H
    Biomed Sci Instrum; 2005; 41():376-81. PubMed ID: 15850135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement of experimental allergic encephalomyelitis (EAE) by thymoquinone; an oxidative stress inhibitor.
    Mohamed A; Shoker A; Bendjelloul F; Mare A; Alzrigh M; Benghuzzi H; Desin T
    Biomed Sci Instrum; 2003; 39():440-5. PubMed ID: 12724933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amelioration of experimental allergic encephalitis (EAE) through phase 2 enzyme induction.
    Mohamed AA; Avila JG; Schültke E; Kamencic H; Skihar V; Obayan A; Juurlink BH
    Biomed Sci Instrum; 2002; 38():9-13. PubMed ID: 12085664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High interleukin-10 expression within the central nervous system may be important for initiation of recovery of Dark Agouti rats from experimental autoimmune encephalomyelitis.
    Blaževski J; Petković F; Momčilović M; Jevtic B; Miljković D; Mostarica Stojković M
    Immunobiology; 2013 Sep; 218(9):1192-9. PubMed ID: 23664544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ellagic acid protects from myelin-associated sphingolipid loss in experimental autoimmune encephalomyelitis.
    Busto R; Serna J; Perianes-Cachero A; Quintana-Portillo R; García-Seisdedos D; Canfrán-Duque A; Paino CL; Lerma M; Casado ME; Martín-Hidalgo A; Arilla-Ferreiro E; Lasunción MA; Pastor Ó
    Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Sep; 1863(9):958-967. PubMed ID: 29793057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epimedium flavonoids ameliorate experimental autoimmune encephalomyelitis in rats by modulating neuroinflammatory and neurotrophic responses.
    Yin LL; Lin LL; Zhang L; Li L
    Neuropharmacology; 2012 Oct; 63(5):851-62. PubMed ID: 22728315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of ribavirin on reactive astrogliosis in experimental autoimmune encephalomyelitis.
    Lavrnja I; Savic D; Bjelobaba I; Dacic S; Bozic I; Parabucki A; Nedeljkovic N; Pekovic S; Rakic L; Stojiljkovic M
    J Pharmacol Sci; 2012; 119(3):221-32. PubMed ID: 22785017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of digital technology to asses the severity of the Experimental Allergic Encephalomyelitis (EAE) spinal cord lesion.
    Mohamed A; Tarhuni H; Dufan T; Benghuzzi H; Tucci M
    Biomed Sci Instrum; 2004; 40():419-23. PubMed ID: 15133994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical analysis of the rat central nervous system during experimental allergic encephalomyelitis, with special reference to Ia-positive cells with dendritic morphology.
    Matsumoto Y; Hara N; Tanaka R; Fujiwara M
    J Immunol; 1986 May; 136(10):3668-76. PubMed ID: 3084638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental autoimmune encephalomyelitis in the maturing central nervous system. Transfer of myelin basic protein-specific T line lymphocytes to neonatal Lewis rats.
    Umehara F; Qin YF; Goto M; Wekerle H; Meyermann R
    Lab Invest; 1990 Feb; 62(2):147-55. PubMed ID: 1689408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amelioration of experimental autoimmune encephalomyelitis by curcumin treatment through inhibition of IL-17 production.
    Xie L; Li XK; Funeshima-Fuji N; Kimura H; Matsumoto Y; Isaka Y; Takahara S
    Int Immunopharmacol; 2009 May; 9(5):575-81. PubMed ID: 19539560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The distribution of inflammatory demyelinated lesions in the central nervous system of rats with antibody-augmented demyelinating experimental allergic encephalomyelitis.
    Meeson AP; Piddlesden S; Morgan BP; Reynolds R
    Exp Neurol; 1994 Oct; 129(2):299-310. PubMed ID: 7525334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thymoquinone inhibits the activation of NF-kappaB in the brain and spinal cord of experimental autoimmune encephalomyelitis.
    Mohamed A; Afridi DM; Garani O; Tucci M
    Biomed Sci Instrum; 2005; 41():388-93. PubMed ID: 15850137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beneficial effect of modified peptide inhibitor of alpha4 integrins on experimental allergic encephalomyelitis in Lewis rats.
    van der Laan LJ; van der Goes A; Wauben MH; Ruuls SR; Döpp EA; De Groot CJ; Kuijpers TW; Elices MJ; Dijkstra CD
    J Neurosci Res; 2002 Jan; 67(2):191-9. PubMed ID: 11782963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amelioration of experimental autoimmune encephalomyelitis in Lewis rats treated with fucoidan.
    Kim H; Moon C; Park EJ; Jee Y; Ahn M; Wie MB; Shin T
    Phytother Res; 2010 Mar; 24(3):399-403. PubMed ID: 19655293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic effects of cisplatin on rat experimental autoimmune encephalomyelitis.
    Li XB; Schluesener HJ
    Arch Immunol Ther Exp (Warsz); 2006; 54(1):51-3. PubMed ID: 16642257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined nasal administration of encephalitogenic myelin basic protein peptide 68-86 and IL-10 suppressed incipient experimental allergic encephalomyelitis in Lewis rats.
    Xu LY; Yang JS; Huang YM; Levi M; Link H; Xiao BG
    Clin Immunol; 2000 Sep; 96(3):205-11. PubMed ID: 10964538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic permeability of the central nervous system to mononuclear cells in experimental allergic encephalomyelitis in the Lewis rat.
    Stohl W; Gonatas NK
    J Immunol; 1978 Sep; 121(3):844-50. PubMed ID: 308523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of endogenous Type I interferon within the central nervous system plays a protective role in experimental autoimmune encephalomyelitis.
    Khorooshi R; Mørch MT; Holm TH; Berg CT; Dieu RT; Dræby D; Issazadeh-Navikas S; Weiss S; Lienenklaus S; Owens T
    Acta Neuropathol; 2015 Jul; 130(1):107-18. PubMed ID: 25869642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blocking glutamate carboxypeptidase II inhibits glutamate excitotoxicity and regulates immune responses in experimental autoimmune encephalomyelitis.
    Ha D; Bing SJ; Ahn G; Kim J; Cho J; Kim A; Herath KH; Yu HS; Jo SA; Cho IH; Jee Y
    FEBS J; 2016 Sep; 283(18):3438-56. PubMed ID: 27444540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.